137 related articles for article (PubMed ID: 8610388)
1. Cytomegalovirus-induced CD13-specific autoimmunity--a possible cause of chronic graft-vs-host disease.
Soderberg C; Larsson S; Rozell BL; Sumitran-Karuppan S; Ljungman P; Moller E
Transplantation; 1996 Feb; 61(4):600-9. PubMed ID: 8610388
[TBL] [Abstract][Full Text] [Related]
2. CD13-specific autoimmunity in cytomegalovirus-infected immunocompromised patients.
Soderberg C; Sumitran-Karuppan S; Ljungman P; Moller E
Transplantation; 1996 Feb; 61(4):594-600. PubMed ID: 8610387
[TBL] [Abstract][Full Text] [Related]
3. Anti-CD13 Abs in children with extensive chronic GVHD and their relation to soluble CD13 after allogeneic blood and marrow transplantation from a Children's Oncology Groups Study, ASCT0031.
Cuvelier GD; Kariminia A; Fujii H; Aslanian S; Wall D; Goldman F; Grupp SA; Dunn SE; Krailo M; Shapiro LH; Gilman A; Schultz KR
Bone Marrow Transplant; 2010 Nov; 45(11):1653-7. PubMed ID: 20190833
[TBL] [Abstract][Full Text] [Related]
4. A novel mechanism for virus-induced autoimmunity in humans.
Nauclér CS; Larsson S; Möller E
Immunol Rev; 1996 Aug; 152():175-92. PubMed ID: 8930673
[TBL] [Abstract][Full Text] [Related]
5. Neutralization of human cytomegalovirus by human CD13-specific antibodies.
Giugni TD; Söderberg C; Ham DJ; Bautista RM; Hedlund KO; Möller E; Zaia JA
J Infect Dis; 1996 May; 173(5):1062-71. PubMed ID: 8627055
[TBL] [Abstract][Full Text] [Related]
6. Antibodies against human cytomegalovirus late protein UL94 in the pathogenesis of scleroderma-like skin lesions in chronic graft-versus-host disease.
Pastano R; Dell'Agnola C; Bason C; Gigli F; Rabascio C; Puccetti A; Tinazzi E; Cetto G; Peccatori F; Martinelli G; Lunardi C
Int Immunol; 2012 Sep; 24(9):583-91. PubMed ID: 22773152
[TBL] [Abstract][Full Text] [Related]
7. Productive cytomegalovirus (CMV) infection exclusively in CD13-positive peripheral blood mononuclear cells from CMV-infected individuals: implications for prevention of CMV transmission.
Larsson S; Söderberg-Nauclér C; Möller E
Transplantation; 1998 Feb; 65(3):411-5. PubMed ID: 9484762
[TBL] [Abstract][Full Text] [Related]
8. Detection of cytotoxic CD13-specific autoantibodies in sera from patients with ulcerative colitis and Crohn's disease.
Rahbar A; Boström L; Söderberg-Naucler C
J Autoimmun; 2006 May; 26(3):155-64. PubMed ID: 16584867
[TBL] [Abstract][Full Text] [Related]
9. CD13/aminopeptidase N and murine cytomegalovirus infection.
Kasman LM
Virology; 2005 Mar; 334(1):1-9. PubMed ID: 15749117
[TBL] [Abstract][Full Text] [Related]
10. Salivary immunoglobulins in recipients of bone marrow grafts. III. A longitudinal follow-up of CMV specific antibodies.
Chaushu G; Chaushu S; Slavin S; Or R; Garfunkel AA; Yefenof E
Bone Marrow Transplant; 1996 Feb; 17(2):237-41. PubMed ID: 8640173
[TBL] [Abstract][Full Text] [Related]
11. Humoral immunity to cytomegalovirus and chronic graft-versus-host disease.
Namboodiri AM; Nietert PJ; Wadia PP; Miklos DB; Pandey JP
Viral Immunol; 2012 Aug; 25(4):338-40. PubMed ID: 22803743
[TBL] [Abstract][Full Text] [Related]
12. Donor-derived regulatory B cells are important for suppression of murine sclerodermatous chronic graft-versus-host disease.
Le Huu D; Matsushita T; Jin G; Hamaguchi Y; Hasegawa M; Takehara K; Tedder TF; Fujimoto M
Blood; 2013 Apr; 121(16):3274-83. PubMed ID: 23422748
[TBL] [Abstract][Full Text] [Related]
13. Diverse Activity of IL-17
Klimczak A; Suchnicki K; Sedzimirska M; Lange A
Arch Immunol Ther Exp (Warsz); 2019 Oct; 67(5):311-323. PubMed ID: 31177288
[TBL] [Abstract][Full Text] [Related]
14. Incidence, risk factors, and outcome of cytomegalovirus viremia and gastroenteritis in patients with gastrointestinal graft-versus-host disease.
Bhutani D; Dyson G; Manasa R; Deol A; Ratanatharathorn V; Ayash L; Abidi M; Lum LG; Al-Kadhimi Z; Uberti JP
Biol Blood Marrow Transplant; 2015 Jan; 21(1):159-64. PubMed ID: 25445637
[TBL] [Abstract][Full Text] [Related]
15. Close association between antibodies to cytoskeletal intermediate filaments, and chronic graft-versus-host disease.
Tazzari PL; Gobbi M; Zauli D; Tassinari A; Crespi C; Miserocchi F; Dinota A; Bandini G; Ricci P; Tura S
Transplantation; 1987 Aug; 44(2):234-6. PubMed ID: 3307047
[TBL] [Abstract][Full Text] [Related]
16. Cytomegalovirus immunity in allogeneic marrow grafting.
Gratama JW; Middeldorp JM; Sinnige LG; van der Meer JW; D'Amaro J; Jansen J; Zwaan FE; Brand A; de Gast GC; The TH
Transplantation; 1985 Nov; 40(5):510-4. PubMed ID: 2997951
[TBL] [Abstract][Full Text] [Related]
17. Antimitochondrial antibodies in patients with chronic graft-versus-host disease.
Siegert W; Stemerowicz R; Hopf U
Bone Marrow Transplant; 1992 Sep; 10(3):221-7. PubMed ID: 1422476
[TBL] [Abstract][Full Text] [Related]
18. Antineutrophil cytoplasmic antibodies (ANCA) in chronic graft-versus-host disease after allogeneic bone marrow transplantation.
Martin SJ; Audrain MA; Oksman F; Ecoiffier M; Attal M; Milpied N; Esnault VL
Bone Marrow Transplant; 1997 Jul; 20(1):45-8. PubMed ID: 9232255
[TBL] [Abstract][Full Text] [Related]
19. Clinical significance of autoantibodies in a large cohort of patients with chronic graft-versus-host disease defined by NIH criteria.
Kuzmina Z; Gounden V; Curtis L; Avila D; Rnp TT; Baruffaldi J; Cowen EW; Naik HB; Hasni SA; Mays JW; Mitchell S; Baird K; Steinberg SM; Pavletic SZ
Am J Hematol; 2015 Feb; 90(2):114-9. PubMed ID: 25363867
[TBL] [Abstract][Full Text] [Related]
20. Biomarkers in newly diagnosed pediatric-extensive chronic graft-versus-host disease: a report from the Children's Oncology Group.
Fujii H; Cuvelier G; She K; Aslanian S; Shimizu H; Kariminia A; Krailo M; Chen Z; McMaster R; Bergman A; Goldman F; Grupp SA; Wall DA; Gilman AL; Schultz KR
Blood; 2008 Mar; 111(6):3276-85. PubMed ID: 17925486
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
